WebApr 11, 2024 · Background: Progesterone receptor (PR)-negative tumors have been shown to have worse prognosis and were underrepresented in recent trials on patients with estrogen receptor (ER)-positive breast cancer. The role of PR-negative status in the context of 21-gene recurrence score (RS) and nodal staging remains unclear. Methods: The … WebApr 13, 2024 · Pathogen Advanced Molecular Detection Database (24447) All of Us Reports and Publications Database (334) ... Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 15 (19): 6208-16. ...
A catalog of curated breast cancer genes SpringerLink
WebJan 13, 2024 · The 21-gene recurrence score (RS) is prognostic for recurrence and predictive of chemotherapy benefit in early estrogen receptor-positive (ER +) HER2-negative (HER2-) breast cancer (BCA). WebDec 23, 1999 · The Breast Cancer Gene Database (BCGD) is a compendium of molecular genetic data relating to genes involved in breast cancer, and which is freely available … the angel candle in advent
Identification of estrogen-responsive genes based on the DNA …
WebDec 12, 2024 · bc-GenExMiner v4.9 is a statistical mining tool of published annotated breast cancer transcriptomic data (DNA microarrays [n = 11 359] and RNA-seq [n = 4 421]). It offers the possibility to explore gene … WebThe Cancer Genome Atlas (TCGA), a landmark cancer genomics program, molecularly characterized over 20,000 primary cancer and matched normal samples spanning 33 … Webbetween a number of putative cancer susceptibility genes and breast cancer risk are now reported in the Journal. The study by Dorling et al2 included 34 genes and 113 000 … theangelcardproject.com